Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Profound Medical Corp. (PROF)

5.28   0.33 (6.67%) 12-02 15:59
Open: 5 Pre. Close: 4.95
High: 5.32 Low: 4.9201
Volume: 123,326 Market Cap: 110(M)

Technical analysis

as of: 2022-12-02 4:25:29 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 6.21     One year: 7.25
Support: Support1: 4.18    Support2: 3.49
Resistance: Resistance1: 5.32    Resistance2: 6.21
Pivot: 4.9
Moving Average: MA(5): 4.84     MA(20): 4.88
MA(100): 5.58     MA(250): 7.59
MACD: MACD(12,26): 0.1     Signal(9): 0.1
Stochastic oscillator: %K(14,3): 62     %D(3): 37.7
RSI: RSI(14): 64.1
52-week: High: 12.06  Low: 3.09
Average Vol(K): 3-Month: 83 (K)  10-Days: 52 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ PROF ] has closed above the upper band by 7.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 63.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.33 - 5.35 5.35 - 5.37
Low: 4.87 - 4.89 4.89 - 4.91
Close: 5.24 - 5.28 5.28 - 5.32

Company Description

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Headline News

Sat, 03 Dec 2022
Don’t defy Prof. Babones bravado, instead introspect - Avenue Mail

Sat, 03 Dec 2022
Short term winter vacation at KU as per need: VC Prof Nilofar - The Dispatch

Sat, 03 Dec 2022
Brock University: Marketing prof wins distinguished teaching competition - India Education Diary

Fri, 02 Dec 2022
Kinesiology Prof. Brian Wright Named Interim Head Coach of DePauw Men's Swimming - SwimSwam

Fri, 02 Dec 2022
Prof suspended for ‘harassing’ pupil - The Tribune India

Fri, 02 Dec 2022
Prof Emejulu, NINLAN boss lauds Aiyeleru on devt strides in French village - Vanguard

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 21 (M)
Shares Float 16 (M)
% Held by Insiders 3.5 (%)
% Held by Institutions 53 (%)
Shares Short 287 (K)
Shares Short P.Month 426 (K)

Stock Financials

EPS -1.53
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.88
Profit Margin (%) 0
Operating Margin (%) -514.4
Return on Assets (ttm) -26.1
Return on Equity (ttm) -39.6
Qtrly Rev. Growth -19.8
Gross Profit (p.s.) 0.14
Sales Per Share 0.3
EBITDA (p.s.) -1.58
Qtrly Earnings Growth 0
Operating Cash Flow -24 (M)
Levered Free Cash Flow -9 (M)

Stock Valuations

PE Ratio -3.47
PEG Ratio 0
Price to Book value 1.83
Price to Sales 17.17
Price to Cash Flow -4.55

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2019-10-15
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.